Uptake of prevention of mother-to-child transmission cascade services in Burkina Faso between 2013 and 2020: are we on the right track?
Burkina Faso
HIV
PMTCT indicators
Regions
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
24 03 2023
24 03 2023
Historique:
received:
19
10
2021
accepted:
13
02
2023
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
The use of services to prevent mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV) remains a serious challenge in sub-Saharan Africa. In the last decade, Burkina Faso has implemented numerous policies to increase the use of PMTCT services by pregnant women and their partners, as well as children. This study assesses trends in the uptake of PMTCT services in Burkina Faso from 2013 to 2020 in order to study the progress and gaps in achieving the national and international targets set for 2020. A repeated cross-sectional analysis was performed using data extracted from district health information software version 2. Percentages were computed for each PMTCT indicator and comparisons between the years were made using a chi-square test for trends with a significance threshold of 5%. Regions were not compared with each other. The proportion of pregnant women who were tested and received their results significantly increased from 47.9% in 2013 to 84.6% in 2020 (p value < 0.001). Of the 13 regions in the country, only 1 region met the 95% national targets whereas, 6 regions met the 90% international targets for this indicator. The proportions of HIV-positive women receiving antiretroviral therapy (ART) increased from 90.8% in 2013 to 100% in 2020. In the same period, the proportion of exposed infants who received antiretroviral prophylaxis increased from 64.3% in 2013 to 86.8% in 2020. Only 3 regions reached the national and international targets for this indicator. A positive trend was also observed for the indicator related to screening at 2 months or later of exposed infants using Polymerase Chain Reaction (PCR) technic; with the rate rising from 7.4% in 2013 to 75.7% in 2020. However, for this indicator, the national and international targets were not achieved considering the national and regional settings. Concerning the women's partners, the proportion of those who tested for HIV increased from 0.9% in 2013 to 4.5% in 2020, with only 1 region that fully met the national target of 10% in 2020. The prevalence of HIV in this particular group was 0.5% in 2020. PMTCT indicators show an increase from 2013 to 2020 but with a strong disparity between regions. National and international targets have not been achieved for any indicator; except for those related to women receiving ART. Strengthening strategies to effectively engage women and their partners on the use of PMTCT cascade services could help reduce mother-to-child transmission in Burkina Faso.
Sections du résumé
BACKGROUND
The use of services to prevent mother-to-child transmission (PMTCT) of the human immunodeficiency virus (HIV) remains a serious challenge in sub-Saharan Africa. In the last decade, Burkina Faso has implemented numerous policies to increase the use of PMTCT services by pregnant women and their partners, as well as children. This study assesses trends in the uptake of PMTCT services in Burkina Faso from 2013 to 2020 in order to study the progress and gaps in achieving the national and international targets set for 2020.
METHODS
A repeated cross-sectional analysis was performed using data extracted from district health information software version 2. Percentages were computed for each PMTCT indicator and comparisons between the years were made using a chi-square test for trends with a significance threshold of 5%. Regions were not compared with each other.
RESULTS
The proportion of pregnant women who were tested and received their results significantly increased from 47.9% in 2013 to 84.6% in 2020 (p value < 0.001). Of the 13 regions in the country, only 1 region met the 95% national targets whereas, 6 regions met the 90% international targets for this indicator. The proportions of HIV-positive women receiving antiretroviral therapy (ART) increased from 90.8% in 2013 to 100% in 2020. In the same period, the proportion of exposed infants who received antiretroviral prophylaxis increased from 64.3% in 2013 to 86.8% in 2020. Only 3 regions reached the national and international targets for this indicator. A positive trend was also observed for the indicator related to screening at 2 months or later of exposed infants using Polymerase Chain Reaction (PCR) technic; with the rate rising from 7.4% in 2013 to 75.7% in 2020. However, for this indicator, the national and international targets were not achieved considering the national and regional settings. Concerning the women's partners, the proportion of those who tested for HIV increased from 0.9% in 2013 to 4.5% in 2020, with only 1 region that fully met the national target of 10% in 2020. The prevalence of HIV in this particular group was 0.5% in 2020.
CONCLUSIONS
PMTCT indicators show an increase from 2013 to 2020 but with a strong disparity between regions. National and international targets have not been achieved for any indicator; except for those related to women receiving ART. Strengthening strategies to effectively engage women and their partners on the use of PMTCT cascade services could help reduce mother-to-child transmission in Burkina Faso.
Identifiants
pubmed: 36959578
doi: 10.1186/s12905-023-02227-0
pii: 10.1186/s12905-023-02227-0
pmc: PMC10036241
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
126Informations de copyright
© 2023. The Author(s).
Références
BMJ Glob Health. 2016 Sep 15;1(2):e000010
pubmed: 28588933
Int J Womens Health. 2020 Dec 08;12:1181-1188
pubmed: 33335430
BMJ Glob Health. 2020 Sep;5(9):
pubmed: 32978211
AIDS Res Treat. 2016;2016:2403936
pubmed: 27872760
Pan Afr Med J. 2015 Apr 23;20:399
pubmed: 26301003
AIDS. 2012 Nov 28;26(18):2361-73
pubmed: 22948267
Pan Afr Med J. 2015 Nov 25;22:303
pubmed: 26966499
Glob Health Action. 2015 Dec 28;8:29987
pubmed: 26715204
J Acquir Immune Defic Syndr. 2017 May 01;75 Suppl 1:S27-S35
pubmed: 28398994
Sci Transl Med. 2012 Jul 18;4(143):143sr3
pubmed: 22814853
Health Policy Plan. 2013 May;28(3):309-19
pubmed: 22773608
Soc Sci Med. 2019 Oct;239:112526
pubmed: 31520880
BMC Int Health Hum Rights. 2015 Apr 03;15:7
pubmed: 25884930
J Int AIDS Soc. 2012 Jul 11;15 Suppl 2:17389
pubmed: 22789644
J Int AIDS Soc. 2019 Oct;22(10):e25388
pubmed: 31631583
BMC Infect Dis. 2019 Sep 16;19(Suppl 1):783
pubmed: 31526371
Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004772
pubmed: 22786492
Bull World Health Organ. 2013 Jan 1;91(1):46-56
pubmed: 23397350
Arch Pediatr. 2021 Aug;28(6):441-450
pubmed: 34140219
J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):e138-45
pubmed: 23274930
J Glob Health. 2021 Jul 10;11:05016
pubmed: 34804513
BMC Health Serv Res. 2016 Jan 06;16:4
pubmed: 26739028
South Afr J HIV Med. 2020 Jun 02;21(1):1084
pubmed: 32537251
Reprod Health Matters. 2007 Nov;15(30):190-201
pubmed: 17938084
AIDS. 2013 Jun 1;27(9):1461-71
pubmed: 23435303
Int J Health Plann Manage. 2018 Jan;33(1):e153-e167
pubmed: 28671285
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD001224
pubmed: 22972050
Med Sante Trop. 2018 Aug 1;28(3):307-311
pubmed: 30270837
J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):e74-81
pubmed: 26009838
AIDS. 2013 Nov 13;27(17):2787-97
pubmed: 24056068
Ethiop J Health Sci. 2018 Jul;28(4):413-422
pubmed: 30607054
J Public Health (Oxf). 2021 Apr 12;43(1):e77-e84
pubmed: 31786595